Clifford Chance Guides Cinven's $589M Pharma Co. Buy
Per an agreement, the acquisition will be financed by a mix of deb and cash, Rebecca Flower, a spokeswoman for Cinven, told Law360. The deal will leave Amdipharm's founders with a significant, but unspecified stake, according to Cinven.
While the company will continue to operate as a stand-alone business immediately...
To view the full article, register now.